Xigris 2011: deja vu all over again?

Crit Care Resusc. 2011 Dec;13(4):211-2.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Early Termination of Clinical Trials
  • Fibrinolytic Agents / adverse effects*
  • Humans
  • Protein C / adverse effects*
  • Recombinant Proteins / adverse effects
  • Safety-Based Drug Withdrawals*

Substances

  • Fibrinolytic Agents
  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated